NeuroOne Medical Technologies Corporation (NMTC)
After hours:
| Previous close | 1.1600 |
| Open | 1.1800 |
| Bid | 1.0900 x 100 |
| Ask | 1.1600 x 100 |
| Day's range | 1.0100 - 1.1800 |
| 52-week range | 0.8500 - 2.0000 |
| Volume | |
| Avg. volume | 209,391 |
| Market cap | 29.043M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6800 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.15 |
GlobeNewswireNeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update. Conference Call
Simply Wall St.Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
- GlobeNewswire
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by Chief Executive Officer Dave Rosa on Bloomberg Television's Bloomberg Technology. A replay of the segment, which aired live yesterday, can be viewed at NeuroOne-Bloomberg. In conversation with
